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Abstract
Introduction Campylobacter jejuni is the leading cause of foodborne bacterial enteritis in humans, and yet little is known in 
regard to how genetic diversity and metabolic capabilities among isolates affect their metabolic phenotype and pathogenicity.
Objectives For instance, the C. jejuni 11168 strain can utilize both l-fucose and l-glutamate as a carbon source, which 
provides the strain with a competitive advantage in some environments and in this study we set out to assess the metabolic 
response of C. jejuni 11168 to the presence of l-fucose and l-glutamate in the growth medium.
Methods To achieve this, untargeted hydrophilic liquid chromatography coupled to mass spectrometry was used to obtain 
metabolite profiles of supernatant extracts obtained at three different time points up to 24 h.
Results This study identified both the depletion and the production and subsequent release of a multitude of expected and 
unexpected metabolites during the growth of C. jejuni 11168 under three different conditions. A large set of standards 
allowed identification of a number of metabolites. Further mass spectrometry fragmentation analysis allowed the additional 
annotation of substrate-specific metabolites. The results show that C. jejuni 11168 upon l-fucose addition indeed produces 
degradation products of the fucose pathway. Furthermore, methionine was faster depleted from the medium, consistent with 
previously-observed methionine auxotrophy.
Conclusions Moreover, a multitude of not previously annotated metabolites in C. jejuni were found to be increased specifi-
cally upon l-fucose addition. These metabolites may well play a role in the pathogenicity of this C. jejuni strain.
Keywords Campylobacter jejuni · Metabolomics · HILIC chromatography · Mass spectrometry fragmentation · Sulphur 
metabolism
1 Introduction
Campylobacter jejuni is a significant and relevant zoonotic 
pathogen as a frequent cause of debilitating intestinal infec-
tion. C. jejuni are the commonest causes of foodborne 
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infections in most developed countries (Sheppard et al. 2012) 
and are also considered to be the commonest cause of enteric 
disease in children in developing countries (Platts-Mills and 
Kosek 2014). For instance, the recent intestinal infectious 
disease (IID2) survey in the UK estimates ~ 65,000 Campy-
lobacter cases per annum resulting in a cost to the economy 
of approximately £900 million. Similar impact is recorded 
across European countries as well as US and Canada. The 
major reported sources of human Campylobacter infections 
are livestock animals in which these bacteria are widely dis-
tributed. Notably, poultry act as the main source of human 
infection although ruminants and pigs are also recognised as 
reservoirs of these zoonotic infections (Zorman et al. 2006; 
Hutchison et al. 2005; Hermans et al. 2011). Campylobacters 
are usually carried in animals in the absence of overt signs 
of disease, although exposure of humans typically results 
in enteric disease. Campylobacter’s metabolism has been 
associated with its pathogenicity through epidemiological 
and genomics studies (Zautner et al. 2011, 2012; de Haan 
et al. 2012).
Campylobacter jejuni and related species are near-ubiqui-
tous residents of the intestinal tracts of mammalian and avian 
species and many studies show limited survivability outside 
these niches. It is widely reported that metabolic capabilities 
of Campylobacter species are restricted in comparison to 
other common intestinal tract residents (e.g. Bacteroidetes 
and E. coli) hence, C. jejuni and related species have been 
considered to be metabolically fastidious. Characterisation 
of metabolic capabilities of Campylobacters has mainly 
focussed on defining substrates utilised as energy and/or 
carbon sources and on associated proteins/genes. Notably, C. 
jejuni and Campylobacter coli are typically non-glycolytic, 
lacking both necessary sugar transport systems and several 
enzymes involved in glycolysis (Hofreuter 2014; Wagley 
et al. 2014). Rather, these bacteria utilise several TCA cycle 
intermediaries (pyruvate; malate; succinate; fumarate), some 
organic acids (acetate; lactate; hydroxylbutyrate; formate) 
and several amino acids as substrates (Mohammed et al. 
2004; Stahl et al. 2012; Wright et al. 2009), and C. jejuni 
strains were observed to be methionine auxotrophic (Alaz-
zam et al. 2011; Tenover and Patton 1987). Several investi-
gations have identified aspartic acid, glutamic acid, proline 
and serine as primary amino acid substrates (Wagley et al. 
2014; Wright et al. 2009) for many strains whilst selected 
strains of C. jejuni possess determinants which permit uti-
lisation of additional amino acids, principally asparagine 
and glutamine, and oligopeptides like γ-glutamyl-cysteine 
and glutathione (Hofreuter et al. 2008). Also, although not 
utilised as a carbon source, cysteine has recently been iden-
tified as a crucial source of sulphur (Vorwerk et al. 2014).
Furthermore, despite being classified as asaccharolytic, 
some Campylobacter strains can utilise fucose (Muraoka 
and Zhang 2011; Stahl et al. 2011) although the utilisation 
pathway for fucose has not been entirely specified in Campy-
lobacter. Fucose is a common mucin component and chem-
oattractant (Muraoka and Zhang 2011; Wisessombat et al. 
2010; Tu et al. 2008); which influences gene expression and 
an advantage in neonatal piglet intestinal colonisation by 
fucose use was reported (Muraoka and Zhang 2011; Stahl 
et al. 2011). Mucin is a major component of mucus—it can 
be regarded as the interface of the gastrointestinal mucosa 
with micro-organisms and it provides viscous consistency 
(Freitas and Cayuela 2000). Fucose can be present in the gut 
as a breakdown product of mucus where it is produced and 
released by other gut colonizers. Transcriptomics analysis 
showed large changes in transcript abundancies upon pres-
ence of fucose with 74 transcripts up-regulated and another 
52 down-regulating (Stahl et al. 2011), suggesting a broader 
impact than merely activating the fucose breakdown path-
way. Significantly, the capacity of C. jejuni strains to utilise 
“accessory” substrates such as fucose has been shown to 
correlate with colonisation and pathogenicity in avian and 
mammalian species. For instance, the ability to utilise glu-
tamine has been shown to provide an advantage in colonisa-
tion of chicken and mouse intestinal tracts (Hofreuter et al. 
2008; Barnes et al. 2007).
Glutamic acid is one of the four preferential amino acids 
of Campylobacter (Wagley et al. 2014; Hofreuter et al. 
2008; Guccione et al. 2008) and its presence in the gut is 
mainly from a dietary source, in particular processed food. 
We therefore postulate that the influence of the nutritional 
milieu in each of these host species and the adaptation of 
C. jejuni to the conditions prevailing in each of these dif-
ferent intestinal environments is of relevance to infectivity 
and pathogenicity.
Investigations into the metabolic capabilities of C. jejuni 
and establishing how these contribute to niche occupation, 
host species colonisation and virulence have recently begun 
(Howlett et al. 2014) to both improve understanding and 
offer options towards disease control of Campylobacter 
spp. Hence, gaining a clearer understanding of metabolism 
of these pathogens and the influence of different substrates 
on their physiology is important in defining adaptation and 
colonisation in the different host niches as well as—poten-
tially—pathogenicity. To date, there have been few system-
atic evaluations of the influence of carbon/energy sources 
on C. jejuni molecular phenotype. “Global” metabolomics 
characterisation using high resolution mass spectrometry is 
an increasingly useful approach for characterising metabo-
lism (Gao and Xu 2015; Xie et al. 2013) although to date few 
studies have taken advantage of untargeted metabolomics 
approaches to study Campylobacter strains (Howlett et al. 
2014) to gain greater understanding of C. jejuni adaptation 
to availability of substrates.
Herein we present a preliminary survey of the extracel-
lular metabolome in C. jejuni strain 11168, a widely utilised 
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reference strain for which a fully annotated genome sequence 
is available (Parkhill et al. 2000)—provided with either 
excess amounts of l-glutamic acid or l-fucose in growth 
medium. Detailed analysis of Campylobacter’s metabolic 
response has not previously been obtained through metabo-
lomics and here we report the profile of substrates utilised, 
key features of the C. jejuni metabolome, and differential 
metabolome profiles upon supplementation of glutamate and 
fucose. For this analysis, we employed an untargeted hydro-
philic liquid chromatography coupled to mass spectrometry 
(pHILIC-MS) approach focusing on small polar metabolites 
(i.e., m/z ≤ 400 Da), enriched by pHILIC-MS fragmenta-
tion experiments to gain additional structural information 
on detected metabolites.
The approach utilised herein provided 101 metabolite 
assignments across the three media compositions and three 
time points of metabolites that (i) serve as energy sub-
strates, (ii) are part of the core extracellular metabolome 
of C. jejuni, or (iii) are novel metabolites released under 
specific conditions. Of those metabolites, 23 compounds 
were verifiable through comparison with standards. Among 
the 78 compounds for which no standard was present, 39 
could be confidently matched to reference MS/MS data or 
one candidate structure was most likely based on diagnostic 
evidence [Metabolite Standards Initiative Metabolite Identi-
fication (MSI MI) level 2] (Sumner et al. 2007). Our analy-
sis showed utilisation of core and accessory components 
as energy source by C. jejuni, major changes to extracel-
lular metabolome upon relative minor changes to the media 
conditions caused by the production and secretion of novel 
C. jejuni metabolites (see Fig. 5). To date, this is the most 
extensive survey of the C. jejuni extracellular metabolome 
in response to different medium conditions. The study pro-
vides novel insight into the metabolic capabilities of this 
important zoonotic pathogen as well as new avenues to 
investigate environmental adaptability and disease control 
for this organism.
2  Materials and methods
2.1  Bacterial strains and culture preparation
Campylobacter jejuni strain 11168O (original isolate) was 
used in this investigation. This strain is a key reference 
strains used in investigations of many aspects of C. jejuni 
biology. A fully annotated and updated genome sequence 
has been available for variants of this strain since 2000 
(Parkhill et al. 2000) and was updated in 2007 (Gundogdu 
et  al. 2007). Bacteria were stored as glycerol stocks at 
− 80 °C and were recovered on Skirrow’s Agar (E&O Labo-
ratories, Bonnybridge, UK). For metabolome preparation, 
cultures were plated onto replicate Skirrow’s Agar plates 
and cultured for 48 h at 37 °C in an atmosphere compris-
ing 5%  O2, 5%  CO2, 2%  H2, 88%  N2 maintained in an A35 
Anaerobic Workstation (Don Whitley Scientific Limited, 
Shipley, UK). Triplicate media preparations were prepared 
for each of the three media permutations: MEMα (Cata-
logue No. 41061; Life Technologies); MEMα plus 20 mM 
glutamic acid (MEMαG) and MEMα plus 25 mM fucose 
(MEMαF). All media were additionally supplemented with 
20 µM iron(II) sulphate heptahydrate. C. jejuni colonies 
were recovered from plates using adsorbent swabs and sus-
pended in prepared media; absorbance (600 nm) of bacterial 
suspensions was measured and adjusted to 0.01. Then, 5 ml 
of eac broth culture were then transferred to vented Corn-
ing® T25 tissue culture flasks and flasks were incubated 
horizontally to provide for largest possible surface area. 
Culture was carried out in an A35 anaerobic chamber (Don 
Whitley Scientific) with a gas mixture of 5% oxygen:5% 
carbon dioxide:2% hydrogen:88% nitrogen (BOC). These 
growth conditions provided highly reproducible growth of C. 
jejuni 11168, consistently achieving approx.  108 cfu  ml−1 at 
the sampling timepoints of 4 h, and ≥ 109 at 9 h and 24 h in 
all media formulations. Cfu was a much more reliable means 
of standardisation of growth than A600 which was 0.36, 0.69 
and 0.59 for MEMα; MEMαG or MEMαF respectively at 
9 h with cell yield approx.  109.5. Similarly, at 24 h, A600 
values were 0.54, 1.25 and 0.76 respectively whilst cfu  ml−1 
were calculated at  109.4,  109.7,  109.6.
2.2  Sample preparation
At the selected sampling times. 1 ml of culture was removed 
from each of the three replicate cultures for each media for-
mulation, placed into a 1.5 ml Eppendorf tube on ice and 
immediately centrifuged (10,000×g, 5 min) at 4 °C. The 
upper portion (100 µl) of the supernatant was dispensed into 
400 µl of extraction solvent (chloroform:methanol 1:3) and 
the sample was placed on ice for 30 min with occasional 
shaking. Samples were then centrifuged (15,000×g, 3 min, 
4 °C) and the upper 200 µl of each sample was removed and 
stored at − 80 °C until analysed by LC–MS.
2.3  Analytical instrumentation and settings
2.3.1  Chromatography
The samples were analysed using a Thermo Scientific 
Ultimate 3000 RSLCnano system (Thermo Scientific, 
CA, USA). The pHILIC separation was performed with 
a SeQuant ZIC-pHILIC column (150 × 4.6  mm, 5  µm) 
equipped with the corresponding pre-column (Merck KGaA, 
Darmstadt, Germany)—the column temperature was main-
tained at 25 °C. A linear biphasic LC gradient was con-
ducted from 80% B to 20% B over 15 min, followed by a 
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2 min wash with 5% B, and 8 min re-equilibration with 80% 
B, where solvent B is acetonitrile and solvent A is 20 mM 
ammonium carbonate in water. The flow rate was 300 µl/
min, column temperature was held at 25 °C, injection vol-
ume was 10 µl, and samples were maintained at 4 °C in the 
autosampler (Creek et al. 2011).
2.3.2  Mass spectrometry
The LC system was coupled to a Thermo Scientific 
Q-Exactive Orbitrap mass spectrometer equipped with a 
HESI II interface (Thermo Scientific, Hemel Hempstead, 
UK). The set up was calibrated (Thermo calmix) in both 
ionization modes and tuned for the lower m/z range before 
analysis. Full scan (MS1) data was acquired in positive and 
negative switching mode in profile mode at 35,000 reso-
lution (at m/z 200) using 1 microscan, an AGC target of 
 106 cts, a maximum injection time of 250 ms, with spray 
voltages + 3.8 and − 3.0 kV, capillary temperature 320 °C, 
heater temperature of 150 °C, sheath gas flow rate 40 a.u., 
auxiliary gas flow rate 5 a.u., sweep gas flow rate 5 a.u., 
a full scan mass window of 70–1050 m/z, and using m/z 
74.0964 (+) and m/z 112.98563 (−) as locking masses.
2.3.3  Mass spectrometry fragmentation
Fragmentation data (LC–MS/MS) of selected samples was 
obtained in positive and negative ionization combined and 
separate fragmentation modes as described in (van der Hooft 
et al. 2016a). Briefly, for separate mode, a duty cycle con-
sisted of one full scan (MS1) event and one Top5 (or Top10) 
MS/MS (MS2) fragmentation event, with full scan (MS1) 
resolution (at m/z 200) was set to 70,000, the AGC target set 
to 1 × 106, and the maximum injection time set to 120 ms. 
MS/MS (MS2) resolution (at m/z 200) was set to 17,500, the 
AGC target set to 2 × 105, MS/MS maximum injection time 
was set to 80 ms and the underfill ratio was set to 10%, with 
a resulting intensity threshold of 2.5 × 105 cts. For combined 
mode, a duty cycle consisted of two of the above events in 
positive and negative ionization mode with the following 
modifications: full scan (MS1) resolution (at m/z 200) was 
set to 35,000, MS/MS resolution was set to 35,000, the AGC 
target was set to 1 × 105, and the maximum MS/MS filling 
time was set to 120 ms with an underfill ratio of 20%, result-
ing in an intensity threshold of 1.7 × 105. Further settings 
were as specified for full scan analysis above.
2.3.4  Data acquisition
Blank runs, quality control samples (beer and serum 
extracts) in accordance with standard procedures at Glasgow 
Polyomics to assess the performance of the mass spectrom-
eter in terms of chromatography and mass intensities, and 
three standard mixes containing 150 reference compounds 
available from Glasgow Polyomics were run to assess the 
quality of the mass spectrometer and to aid in metabolite 
annotation and identification (Creek et al. 2011). Pooled 
sample containing all samples was run prior to and across 
the batch every 6th sample to monitor the stability and qual-
ity of the LC–MS run, whereas the samples were run in a 
randomized order. Thermo Xcalibur Tune software (version 
2.5) was used for instrument control and data acquisition.
Immediately after acquisition, all raw files were converted 
into mzXML format, thereby centroiding the mass spectra 
and separating positive and negative ionization mode spec-
tra into two different mzXML files using the command line 
version of MSconvert (ProteoWizard). Data quality assur-
ance was performed and accurate masses of standards were 
obtained well within 3 ppm accuracy and intensities, pooled 
injections showed low variability, and intensities of the qual-
ity control samples (a beer extract and a serum extract) were 
within specifications.
2.3.5  Data processing and analysis
MzXML files were uploaded into IDEOM (Creek et al. 
2012) and the substrate analysis was performed using the 
resulting peak list from which identified (matched) metabo-
lites were selected. MzXML files were uploaded into PiMP 
(Gloaguen et al. 2017) that relies on XCMS (Smith et al. 
2006) and MzMatch (Scheltema et al. 2011) for LC–MS 
peak picking and alignment across samples. Principal com-
ponent analysis and comparative analysis were performed 
within PiMP. Substrate analysis was performed using the 
identified amino acids and other metabolites present in 
standard mixes run along the samples. Suspect analysis was 
performed by searching for expected m/z masses in the MS1 
peak list (within 3 ppm) and subsequent interpretation of 
retention time and MS/MS spectra, if available, or based 
on the presence of the metabolite feature in a characterized 
cluster (e.g., histidine related). Fold changes and  Log2 fold 
changes were determined for comparisons across different 
conditions and different time points—maximum and mini-
mum  Log2 fold changes were cut off at 13 and − 13, respec-
tively, as they represent complete absence of a metabolite 
feature in one sample and higher/lower values would render 
graphs unreadable and the analytical set up is not able to 
measure higher fold changes accurately within its dynamic 
range. Selection criteria for untargeted metabolite features 
for metabolite annotation/identification are given in Table 1.
2.3.6  Metabolite annotation
Metabolite annotations are reported according to the Metab-
olomics Standards Initiative (MSI) Metabolite Identifica-
tion (MI) levels: (1) for unambiguously identified, (2) for a 
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spectral or literature match, (3) for a metabolite classification 
(e.g., based on Molecular Networking), (4) for metabolites 
that can be characterized by a retention time, mass, and frag-
mentation spectra if available (Sumner et al. 2007). Metabo-
lites that matched to a standard and which fragmentation 
spectrum matched with that of reference MS/MS spectra 
were considered identified (MSI MI Level 1). If no such 
match was found, fragmentation spectra were analysed and 
compared to reference spectral databases [i.e., MzCloud 
(http://www.mzclo ud.org) and Metlin (metlin.scripps.edu) 
(Tautenhahn et  al. 2012)] and analysed using MaGMa 
(http://www.emeta bolom ics.org, Ridder et al. 2013).
2.3.7  Data availability
All MzXML files used for this study were uploaded into the 
GNPS repository (Wang et al. 2016) and can be accessed 
through here: ftp://massi ve.ucsd.edu/MSV00 00812 90. The 
data set consists of both full scan and fragmentation data 
folders with each of them containing positive ionization 
mode and negative ionization mode data folders.
3  Results
3.1  Metabolic responses to added fucose 
and glutamic acid
Initial assessment of the data after processing through PiMP 
using principal component analysis (PCA; Supplementary 
Figure S-1) indicated that biological replicates clustered 
very closely together and, hence, were highly reproduc-
ible. PCA analysis also showed that C. jejuni metabolome 
composition was measurably distinct in each growth 
medium (including at time 0) and that composition changed 
over the course of bacterial growth. Note the substantial 
compositional differences from the 9 to 24 h time points 
indicating a shift in Campylobacter’s metabolism in all three 
conditions. Based on these initial results, the substrate use 
and the changes in excreted metabolites after 4 h and 24 h 
in medium only, l-glutamate addition, and fucose addition 
were investigated in more detail.
3.2  Substrate depletion by Campylobacter jejuni 
under different conditions
Campylobacter jejuni is considered to be a micro-organ-
ism with restricted metabolic capabilities, with TCA cycle 
intermediaries and certain amino acids being recognised 
as common carbon and energy sources. There are many 
reports of the utilisation of serine, proline, glutamate and 
aspartate—along with several TCA cycle intermediates (e.g. 
pyruvate) as primary carbon and energy sources across C. 
jejuni strains (including strain 11168) (Mohammed et al. 
2004; Stahl et al. 2012; Line et al. 2010). In addition to 
utilisation of common substrates, C. jejuni exhibits strain-
dependent metabolic heterogeneity with some strains pos-
sessing genomic loci conferring utilisation of additional 
substrates such as glutamine, asparagine or fucose. Among 
these, C. jejuni strain 11168 possesses the genomic locus 
required for fucose uptake and utilisation (cj0485-cj0490) 
but not ggt (γ-glutamyl-transferase) or ansBs (periplasmic 
asparaginase) required for Gln and Asn utilisation, respec-
tively (de Haan et al. 2012). Moreover, it has recently been 
reported that cysteine represents a crucial source of sulphur 
for C. jejuni (Vorwerk et al. 2014).
Primary amino acid substrates utilised by C. jejuni are 
components of the basal medium selected for this study 
(Supplementary Table 1) and we indeed observe depletion 
of Campylobacter’s preferred amino acid substrates Ser, Pro, 
Asp, and Glu (Wagley et al. 2014; Guccione et al. 2008) 
under all conditions (Fig. 1); with a number of those com-
pletely depleted within 4 h after inoculation. Fucose was 
also found to be depleted in a time-dependent manner in the 
fucose-supplemented medium—indicating use of the locus 
for fucose uptake and utilisation (discussed further below). 
In addition, our results show that this strain also depletes 
Asn, Gln, Cys, Met and Phe from the medium under all 
conditions. Surprisingly, both Asn and Gln were found to be 
depleted under all conditions despite C. jejuni strain 11168 
not having the reported genomic loci for their uptake and 
use. Amongst the additional medium constituents, ascorbic 
acid and nicotinamide are completely depleted under all con-
ditions (Supplementary Figure S-3); and pantothenate was 
also depleted from the medium—an observation not previ-
ously reported. Finally, we did observe an increase in the 
extracellular alanine (Fig. 1); which could be a by-product 
of energy metabolism; however, we cannot discriminate 
between l- and d-alanine in our global approach.
Table 1  Feature selection from untargeted analysis for metabolite 
identification and annotation
Comparisons Log2 FC Intensity # Features
24 h Fuc/4 h Fuc and 24 h 
Fuc/24 h Med
≥ 6 ≥ 2E6
24 h Fuc
25
24 h Fuc/4 h Fuc and 24 h 
Fuc/24 h Med
≤ − 1.5 ≥ 2E6
4 h Med
7
24 h Glu/4 h Glu and 24 h 
Glu/24 h Med
≥ 1.5 ≥ 5E6
24 h Glu
23
24 h Glu/4 h Glu and 24 h 
Glu/24 h Med
≤ − 1.5 ≥ 2E6
4 h Med
9
24 h Med/4 h Med ≥ 2 ≥ 2E6
24 h Med
37
4 h Med/24 h Med ≤ − 2 ≥ 2E7
4 h Med
13
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3.3  Core extracellular Campylobacter jejuni 
metabolome
Campylobacter jejuni excreted an unexpectedly high number 
of metabolites into the medium under all conditions. Given 
the high number of features [unique mass/charge-retention 
time (m/z-RT) pairs] that were found to be released by C. 
jejuni over the time course sampled, we set out to anno-
tate a selected subset of those features (see Methods sec-
tion) which resulted in 32 metabolite annotations (Fig. 2, 
Supplementary Table S-2). As can be observed, most of 
those metabolites are part of a common set of metabolites 
released into medium upon C. jejuni growth, independ-
ent of the conditions tested here. Amongst those, a num-
ber of cysteine-related metabolites were found such as the 
LuxS signalling pathway related S-adenosylmethionine and 
S-ribosyl-homocysteine (Plummer 2012; Vendeville et al. 
2005). In addition, several purine metabolites, for example 
adenine and uracil, were increasingly present in the extracel-
lular media. Nucleotides like adenosine have been reported 
as potential signalling molecules as well as small molecules 
involved in host–microbe interactions (Idzko et al. 2014). 
The metabolite with the greatest fold change we observed 
was 5-hydroxyindoleacetate (or an hydroxyindoleacatate 
isomer), a tryptophan metabolite, with a potential signal-
ling role or host interaction like many other indole-based 
metabolites (Berstad et al. 2015) (see also Supplementary 
Information Sect. 1). There were some noticeable excep-
tions of core metabolites that were not or to a lesser extent 
released into the medium: e.g., S-(2-hydroxyethylmercapto)-
cysteine (CYSSME), not commonly reported as being pro-
duced by bacteria. Furthermore, S-methylsuccinyl-homo-
cysteine was released in higher abundancies by C. jejuni 
under excess glutamic acid.
A common set of metabolites was depleted from medium 
as found by comparing 4 h and 24 h non-supplemented 
MEMα samples of which we were able to annotate a subset 
of 8 (Supplementary Figure S-4). Again, we note depletion 
of methionine, notably its use by C. jejuni increased by the 
presence of both Glutamic acid and fucose. Thiomorphili-
neCOOH; however, is used less upon the presence of excess 
glutamic acid and fucose.
3.4  Excess of glutamic acid presence alters 
metabolism of Campylobacter jejuni
The presence of excess glutamic acid (20 mM compared to 
0.51 mM in unsupplemented medium) substantially changed 
the extracellular metabolome of C. jejuni with an (increased) 
presence of acetylated species (Supplementary Table S-2). 
As evident from Fig. 3, differential metabolites that are more 
abundantly released in the presence of excess glutamic acid 
are also increased in the presence of excess fucose. Some 
metabolites—N-acetylasparate and N-acetylthreonine, for 
example—are also released in absence of supplementation, 
although to a lesser extent. Again, there are several excep-
tions: Thymidine, N-acetyl-3-thioxo-proline, N6-acetylly-
sine, N-acetylglutamine, malate, uracil, and N-acetyl-etha-
nolamine are released in higher abundancies upon glutamic 
acid supplementation than fucose supplementation (Fig. 3). 
Thus, it seems likely that an excess of glutamic acid acti-
vates the acetylation of proteins, peptides and/or amino acids 
(Hu et al. 2010).
Campylobacter metabolizes glutamic acid under micro-
aerobic conditions through the aspartate pathway with alpha-
ketoglutarate (2-oxoglutarate) as intermediate and acetate as 
one of the products (Stahl et al. 2012; Guccione et al. 2008; 
Buckel and Barker 1974; Del Leon-Kempis et al. 2006; 
Laanbroek et al. 1978). We do observe increased release of 
2-hydroxyglutarate, a related metabolite to alpha-ketoglut-
arate (Fig. 3). Acetate is too small to be observed with the 
methodologies used in this study and it can be used as sub-
strate by Campylobacter as well, but we could expect an 
increase in acetate due to increased availability and turnover 
of glutamic acid. Thus, another explanation for the increased 
acetylated amino acids might be the increased available 
acetate pool that activates acetylation enzymes or results 
in chemical addition of the acetyl group to available mol-
ecules. However, we observe numerous metabolites released 
into the environment in higher abundancies upon glutamic 
Fig. 1  Amino acid analysis using IDEOM identifications to deter-
mine  Log2 fold changes (mean of triplicate measurements) of amino 
acid peaks of 24  h compared with 0  h samples for medium only 
(Med), medium supplemented with fucose (Fuc), and medium sup-
plemented with glutamic acid (Glu). It can be seen that several amino 
acids are preferably depleted from the medium. Further inspection 
revealed that aspartic acid, glutamine, methionine, proline, and serine 
are all completely depleted from the medium within 4 h. Glutamate 
was depleted under all conditions; in the glutamate-supplemented 
condition the  Log2 fold change is less pronounced due to the gluta-
mate surplus abundance
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acid addition (see also Supplementary Sect. 2) including the 
acetylated amino acids which may influence the virulence 
and metabolism of C. jejuni.
3.5  Fucose presence induces production of novel 
Campylobacter metabolites
3.5.1  Differential metabolites in fucose added extracellular 
metabolome
Fucose addition to the growth medium caused substantial 
changes in the extracellular metabolome of C. jejuni at all 
three timepoints (4, 9, and 24 h after inoculation)—more so 
than glutamic acid supplementation based on the PCA (see 
Supplementary Figure S-1). Indeed, when investigating the 
most differential features in the extracellular metabolome 
upon fucose supplementation (Fig. 4a, Supplementary Table 
S-2), we can observe that all but one metabolite are specific 
for fucose supplementation. Further inspection revealed 
that the metabolite that also appeared to occur upon glu-
tamic acid supplementation, hydroxypropyl-thiazolidine-
4-carboxilic acid, was detected in both positive and negative 
mode ionization and in negative mode the 24 h glutamic acid 
samples contained minute amounts of a metabolite similar in 
mass (whereas nothing appeared after 4 or 9 h). In fact, the 
positive mode detection better reflects the differential secre-
tion of this metabolite (see also Supplementary Table 2). 
Amongst the fucose-dependent metabolites, we observe 
thiazolidine-containing metabolites, leucine metabolites, 
and N2-propionylarginine. The thiazolidine ring structure 
is present in many biological active structures such as yersin-
iabactin, a siderophore, and thiocillins, an antibiotic family, 
thus its increased presence in the extracellular metabolome 
could indicate the activation of metabolic pathways generat-
ing bioactive factors.
We observed strong depletion of cystine, methionine, 
methionine-sulfoxide, and thiomorpholinecarboxylic acid, 
with the latter two presumably being chemically-formed 
products of methionine in the medium as they do not form 
part of the original growth medium mix. These are all 
sulphur-containing metabolites, which fits in well with the 
observation of sulphur-containing thiazolidines (cysteine 
metabolites) that are formed upon fucose supplementation. 
This observation also fits with previous studies showing 
Campylobacters to be methionine auxotrophic (Alazzam 
et al. 2011; Tenover and Patton 1987).
Fig. 2  Upon growth in MEMα medium Campylobacter jejuni 
excreted a unexpectedly high number of metabolites into the medium. 
Plotted are the  Log2 fold changes of selected metabolites based on 
24/4  h non-supplemented MEMα comparison—for all the three 
conditions Med; non-supplemented MEMα (left), Fuc; fucose-sup-
plemented MEMα (middle), Glu; glutamate-supplemented MEMα 
(right). It can be observed that most of the metabolite changes occur-
ring upon growth in MEMα medium are similar across the two treat-
ments and control and form a ‘base metabolic response’; however 
there are some exceptions. Some metabolites were detected in both 
negative and positive mode; hence their double presence here
 J. J. J. van der Hooft et al.
1 3
 144  Page 8 of 15
3.5.2  Metabolic evidence for fucose breakdown pathway 
in Campylobacter
The ability of certain C. jejuni strains to utilise fucose has 
been described although evidence for cognate enzymes and 
reaction intermediaries has been incomplete. Through a 
combination of the untargeted approach and suspect analy-
sis, several compounds corresponding to fucose metabolism 
could be annotated (Supplementary Table S-2 and Supple-
mentary Sect. 3). For example, 2-keto-3-deoxy-l-fuconate 
was picked up by the untargeted approach. Further inspec-
tion revealed two isomers appeared, with l-fuconolactone 
showing a number of fragments similar to δ-gluconic acid-
δ-lactone (the glucose analogue of Fuconolactone which has 
MS/MS data in MzCloud) enabling its structural annota-
tion. Similarly, fuconate was annotated using fragmentation 
Fig. 3  Most-differential metabolomic changes upon glutamate sup-
plementation of selected metabolites based on 24/4 h fucose-supple-
mented and 24  h fucose-supplemented/24  h medium only compari-
sons. It can be observed that a wide range of acylated amino acids 
is excreted into the medium. Some metabolites were detected in both 
negative and positive ionization mode; hence their double presence 
here
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similarities to Gluconate (see Supplementary Sect. 3 and 
Supplementary Figure S-5). Finally, pyruvate is one of 
the final products of the proposed fucose breakdown path-
way. We do observe that pyruvate is depleted less from the 
medium under fucose supplementation (see Supplementary 
Figure S3); however, a possible explanation could be the 
replenishing of the pyruvate pool with products from fucose 
breakdown. Detection of these intermediates provides sup-
porting evidence that fucose metabolism in C. jejuni closely 
functionally resembles that of Xanthomonas campestris as 
postulated by Stahl et al. (2011). Comparison of predicted 
functional motifs of fucose locus proteins sequences from 
X. campestris and C. jejuni identify four potential functional 
orthologues including the permease (Supplementary Table 
S-2) involved in fucose metabolism leaving three enzymes 
unidentified despite metabolic evidence.
3.5.3  Chemical alterations of medium upon addition 
of fucose
Finally, based on observations in the PCA (Supplementary 
Figure S-1) where the 4 h time points are relatively distant 
from each other, we inspected the 0 h control media samples. 
It is noteworthy that the supplementation of medium with 
either glutamic acid or fucose resulted in more additional 
metabolite features than expected; this was more pronounced 
in the fucose-supplemented medium suggesting spontaneous 
formation of adducts in the absence of bacteria. Fragmenta-
tion data obtained from control media and culture superna-
tants were used to create a molecular network in order to 
inspect if particular sets of compounds could be responsible 
for the alterations upon fucose addition. We observed a clus-
ter of compounds present only at 0 h with the fucose supple-
mentation—these slowly decreased in abundance over time 
(Supplementary Sect. 3 and Supplementary Figure S-6). We 
could annotate fucose conjugates to ten different amino acids 
(Supplementary Table S2). Using the molecular network, we 
also annotated additional metabolites belonging to the Thia-
zole and Histidine clusters at later timepoints leading to the 
annotation of Propionylmethionine which is released after 
9 and 24 h into the extracellular metabolome with fucose 
supplementation. Figure 4 also shows Propionylarginine 
was released in these conditions. However, further analysis 
is warranted to investigate if this is generated by C. jejuni 
or a chemical product of these (preferred) amino acids and 
propionic acid exported by C. jejuni.
Thus, we not only observed that fucose was used as addi-
tional carbon source by Campylobacter when available as 
main accessory substrate, but its presence also reprograms 
Campylobacter’s metabolism more widely resulting in the 
release of novel C. jejuni metabolites. Other omics stud-
ies also revealed substantial changes in transcriptome and 
proteome—further evidence that the addition of fucose has 
a significant impact on Campylobacter’s phenotype (Stahl 
et al. 2011; Alghafari 2016).
4  Discussion and conclusions
Campylobacter jejuni is one of the major causes of food-
borne infections. A better understanding of the factors that 
influence its fitness and virulence is crucial for improved 
prevention and treatment. Campylobacter faces challenges 
upon colonization in a host; it has to find itself a niche in 
a hostile environment and at the same time compete with 
other (commensal) bacteria present. Genome sequencing 
of numerous strains has revealed genomic flexibility in C. 
jejuni and C. coli and has indicated possible host-specific 
genotypes but has not yet identified possible virulence 
determinants (Van Putten et al. 2009; Yahara et al. 2017). 
Similarly, genome-wide functional screening (using mutant 
panels) is beginning to provide evidence for fitness, coloni-
sation and virulence determinants besides flagella and glyco-
sylation systems (de Vries et al. 2017a, b). To date, C. jejuni 
has been subject to metabolomics studies where novel gly-
cosylation events of flagella were observed (McNally et al. 
2007, 2006; Logan et al. 2009), resistance to antibiotic (Li 
et al. 2015), metabolic mutant differentiation (Howlett et al. 
2014), and preferential utilisation of amino acids was shown 
through NMR analysis of depletion from complex growth 
medium (Wright et al. 2009).
Our study represents the first global (untargeted) metabo-
lomics analysis of the extracellular metabolome of C. jejuni 
and its response to the presence of excess supplementary 
carbon sources. Although untargeted metabolomics studies 
have the technical limitation of not providing absolute quan-
tifications for the measured metabolites, increasing the spec-
trum of small molecules reported could provide additional 
valuable insights into novel compounds with potential roles 
in microbe–microbe and microbe–host interactions. There-
fore, we assessed the impact of either glutamate or fucose 
supplementation of growth medium on the C. jejuni strain 
11168 phenotype by its substrate usage and extracellular 
metabolome as readouts.
Our findings show that Campylobacter produces a large 
variety of metabolites even without supplementation and 
that the added substrates cause increased and enriched 
secretion of small molecules (Fig. 5). Our treatments may 
reflect events consequent to ‘local enrichment’ of fucose or 
glutamic acid—arising through host, gut co-colonizers or 
dietary events—as a result of which Campylobacter alters 
metabolite production and export thus influencing its impact 
on competing bacteria as well as host function. For exam-
ple, mercaptomethylglutaric acid was found to be released 
in higher abundancies upon both glutamic acid and fucose 
supplementation. It has been reported that this metabolite 
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inhibits gamma-glutamyl hydrolase (Whitehead et al. 1987), 
an enzyme involved in the metabolism of folates.
We confirmed substrates as serine, proline, aspartate, and 
glutamate, as well as glutamine (all used as carbon sources) 
were depleted from the MEMα medium. Additionally, 
methionine and cystine were depleted from the medium sup-
porting a previous study indicating methionine auxotrophy 
among Campylobacters and use of Cys as sulphur source 
(Alazzam et al. 2011; Tenover and Patton 1987; Vorwerk 
et al. 2014). To this we add the novel observation that phe-
nylalanine was also depleted. This observation suggests 
that Campylobacter may have additional metabolic capa-
bilities and utilise additional substrates although it remains 
to be determined precisely what metabolic process(es) are 
involved.
This indicates that the sensing, transport, and breakdown 
pathways for those amino acids may play significant roles 
in metabolism of some strains which may contribute to 
occupation of specific niches. We could also observe that 
those amino acids were depleted even when surplus of Glu 
or Fuc were supplied and were entirely depleted by 4 h. The 
equivalent depletion of these amino acids challenges the 
idea of sequential utilisation of substrates as suggested by 
other studies (Wright et al. 2009), but would suggest a more 
simultaneous and dynamic use of carbon sources. Indeed, 
it supports the hypothesis that Campylobacter “senses” the 
nutritional compositions of the (gut) environment and adapts 
its metabolism in response to that (Reuter and Vliet 2013).
Over time, Campylobacter not only depleted amino acids 
and other constituents from the medium, but also excreted 
a range of metabolites into the medium (Fig. 2). Compari-
son of the  Log2 fold changes of the medium without and 
with supplementation shows that these changes could be 
considered as ‘core extracellular metabolome’ produced by 
providing the essential compounds for growth. Notably, a 
number of metabolites previously described to be involved in 
chemical signalling (LuxS pathway metabolites and purine 
metabolites) were among those with the largest fold-change 
(Fig. 2), suggesting increased activity of this pathway which 
is associated with virulence (Plummer 2012). Both gluta-
mate and fucose supplementation promote the growth of 
this strain to similar extents yet the effects on metabolome 
are profoundly distinct. Upon glutamic acid supplementa-
tion (Fig. 3), we mainly observe ‘enhanced production’ of 
metabolites, in particular a variety of acetyl-amino acids. 
Amongst others, the aforementioned Mercaptomethylglu-
taric Acid was annotated, as well as N-acetylethanolamine 
which is another potential signalling molecule released upon 
glutamate acid supplementation.
Upon addition of fucose, an even greater number of 
metabolites are released into the extracellular metabo-
lome with sulphur-containing metabolites being dominant 
(Fig. 4). The global changes we observe in the extracellu-
lar metabolome reflect those measured by microarray, i.e. 
not specific to fucose uptake and utilisation pathway (Stahl 
et al. 2011; Alghafari 2016). Thus, the presence and use of 
fucose has major influence on physiology of C. jejuni strain 
11168—and presumably on other fucose locus-positive 
strains that predominate in human infections—by repro-
gramming its metabolism. This interesting area warrants 
further investigation as to if and how these metabolites are 
bioactive in the gut environment.
Notably, the metabolic pathway by which fucose is uti-
lised in C. jejuni has not been fully elucidated. A previous 
study (Stahl et al. 2011) identified potential similarity to the 
fucose pathway of Xanthomonas campestris pv. campestris; 
however, this was not confirmed via detection of metabolites 
or by demonstration of orthologues of the genes encoding 
fucose utilisation enzymes hence remained speculative. Our 
metabolomics analysis has added evidence specifying fucose 
utilisation in C. jejuni by recognizing intermediates in the 
fucose breakdown pathway such as Fuconolactone and Fuco-
nate. Further functional prediction of both X. campestris and 
C. jejuni fucose locus proteins identified 4 potential func-
tional orthologues in the latter although further investigation 
will be necessary to verify their activities (see Supplemen-
tary Table S2).
The global metabolomic profiling approach based on 
pHILIC-MS combined with MS/MS experiments as aid in 
structural elucidation of metabolites by spectral matching, 
in-silico predictions (Ridder et al. 2013) and molecular net-
working (Wang et al. 2016) has proven to be a successful 
approach to gain additional insights in bacterial phenotypes. 
Note that 23 out of the 101 metabolites presented in this 
paper could be matched to a standard (MSI MI level 1), but 
another 39 could be matched to a standard or other candi-
dates could be eliminated based on diagnostic structural evi-
dence (MSI MI level 2), and another 27 could be tentatively 
identified or classified based on their MS/MS patterns (MSI 
MI level 3), leaving only 12 at MSI MI level 4, as metabolic 
features consistently present across a number of samples. 
This underlines the enhanced metabolite annotation power 
that MS/MS experiments can provide. Very recent develop-
ments that group metabolites based on shared substructures 
Fig. 4  Most-differential metabolomic changes upon fucose sup-
plementation of selected metabolites based on 24/4  h fucose-
supplemented and 24  h fucose-supplemented/24  h medium only 
comparisons with metabolites a released into and b depleted from 
the medium. c Breakdown products of fucose were also found to 
be excreted in the medium by Campylobacter, thereby support-
ing the proposal of Stahl et  al. that Campylobacter jejuni possesses 
a Xanthomonas campestris-like fucose utilisation pathway (Stahl 
et  al. 2011). d Molecular networking provided additional evidence 
for metabolites detected only upon fucose supplementation of the 
medium. A number of annotated metabolites were thiazole-contain-
ing (the heteroatomic ring depicted). Arrows point towards examples 
of detected structures
◂
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discovered in and learnt from MS/MS spectra may further 
increase the annotation power and efficiency underlining the 
importance of obtaining fragmentation data of complex bio-
logical extracts full of primary and specialized molecules of 
which the majority is uncharacterized (van der Hooft et al. 
2016b, 2017).
Our observations on substrate usage together with the 
annotation and identification of 101 metabolites in the C. 
jejuni extracellular metabolome preparations indicate that 
provision of this organism with different substrates results 
in substantive alterations to the extracellular metabolome 
suggesting that reprogramming of metabolism is not 
focussed on pathways utilising single substrates but, rather, 
is occurring widely in response to nutrient sources. Our 
study also highlights the importance of good chemical 
analysis of the starting conditions for in vitro studies, as 
addition of one single compound (fucose) can trigger the 
production of several novel compounds that could play a role 
as signalling molecule and/or carbon source. Finally, our 
findings also show that Campylobacter does not have ‘one 
metabolome’, but a core metabolome and a rather adaptive 
metabolome that it changes according to the presence of 
Fig. 5  Schematic overview of study: one bacterial strain under three conditions revealed pleiotropic metabolic effects upon growth whereas two 
different supplementations result in specific metabolic characteristics
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external factors (Fig. 5). Gaining the capability for absolute 
quantification of the measured metabolites in future will help 
assess their potential biological role.
This study indicates that the composition of substrates 
available to C. jejuni in its environment has a major influ-
ence on its physiology which could substantially influence 
colonisation and pathogenicity in this organism’s preferred 
niche, the intestinal tracts of avian and mammalian species.
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